Themis Medicare Limited — PPTs, 25-10-2024: Investor Presentation

Themis Medicare Limited reported robust Q2 FY25 results, with net revenue increasing by 11.67% year-on-year to ₹117 crore. Key growth drivers included the Trade Business (up 45%) and Hospital Business (up 13%). EBITDA rose 38% to ₹17.1 crore, yielding an EBITDA margin of 14.64%. PAT also saw a notable increase of 26.27% to ₹14.29 crore. The company remains focused on expanding its formulations and critical care segments, targeting a 35% CAGR over the next three years.